Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.353536901847331e-56,65.5470737913486,8395.849037095344,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.11919594480306e-54,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.024987939638136e-23,14.450278962914341,737.1084934977977,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",9.132484321529576e-21,0,0,40
3,Nonalcoholic fatty liver disease WP4396,1.4113728615301401e-13,7.35356918568139,217.5850771738961,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS', 'BAX']",1.2231898133261215e-11,0,0,32
4,Mitochondrial CIV Assembly WP4922,2.915263469363788e-10,19.080310880829014,418.92522079813034,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",1.8949212550864623e-08,0,0,15
5,Oxidative phosphorylation WP623,3.2566411058140637e-08,7.246710526315789,124.93317653641276,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.693453375023313e-06,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1837352869860099e-07,7.6280276816609,121.66262271798826,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",5.129519576939377e-06,0,0,16
7,Mitochondrial complex III assembly WP4921,2.2630366625973276e-06,52.756388415672916,685.7698995088734,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",8.405564746790075e-05,0,0,7
8,Cellular Proteostasis WP4918,0.00012381527099599926,37.555178268251275,337.87341791540524,"['VBP1', 'PFDN1', 'PFDN4', 'PFDN5', 'PFDN6']",0.004023996307369976,0,0,5
9,Pyrimidine metabolism WP4022,0.007220885804174828,2.8971285563751317,14.28509672349041,"['NT5C', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.2086033676761617,0,0,10
10,Proteasome Degradation WP183,0.0082185506568177,3.7572402044293014,18.039868105290733,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10']",0.2136823170772602,0,0,7
11,mRNA Processing WP411,0.010516207803340175,4.094619666048238,18.65032766022392,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SRSF9', 'LSM2']",0.24856491171531322,0,0,6
12,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.013985870750440452,inf,inf,"['ELOB', 'ELOC']",0.3030271995928765,0,0,2
13,Iron metabolism in placenta WP2007,0.03865709216867237,14.945945945945946,48.61953616253832,"['HEPHL1', 'FTH1']",0.7731418433734474,0,0,2
14,Prostaglandin Synthesis and Regulation WP98,0.042060073818894254,3.121816638370119,9.891964126019559,"['HSD11B2', 'ANXA3', 'TBXAS1', 'AKR1C3', 'S100A6']",0.7811156566366076,0,0,5
15,Oxidative Damage WP3941,0.058060491675049626,3.326553672316384,9.46826942866014,"['C1QA', 'CYCS', 'NFKBIE', 'C1QC']",0.9981566507682293,0,0,4
16,Dual hijack model of Vif in HIV infection WP3300,0.07129633934175587,7.471283783783784,19.73099025780221,"['ELOB', 'ELOC']",0.9981566507682293,0,0,2
17,Eukaryotic Transcription Initiation WP405,0.10501674181693567,3.2037708484408993,7.220131704004533,"['POLR2I', 'POLR2J', 'POLR2K']",0.9981566507682293,0,0,3
18,Insulin signaling in adipocytes (diabetic condition) WP3635,0.11835001195990445,inf,inf,['RPS6'],0.9981566507682293,0,0,1
19,Insulin signaling in adipocytes (normal condition) WP3634,0.11835001195990445,inf,inf,['RPS6'],0.9981566507682293,0,0,1
20,Mitochondrial CII Assembly WP4920,0.11835001195990445,inf,inf,['SDHAF1'],0.9981566507682293,0,0,1
21,Base Excision Repair WP4752,0.1322377577690717,2.8026649746192893,5.670222241348993,"['POLD4', 'APEX1', 'POLE3']",0.9981566507682293,0,0,3
22,Gastric Cancer Network 2 WP2363,0.15199072927668827,3.7339527027027026,7.0345269913925925,"['S100A6', 'COL9A3']",0.9981566507682293,0,0,2
23,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.15199072927668827,3.7339527027027026,7.0345269913925925,"['EIF3D', 'EIF1']",0.9981566507682293,0,0,2
24,Modulators of TCR signaling and T cell activation WP5072,0.15567458952122235,2.1360774818401937,3.973077233676072,"['ZAP70', 'NDUFB10', 'ELOB', 'RNF7']",0.9981566507682293,0,0,4
25,Nucleotide Excision Repair WP4753,0.16158164759212368,2.490693739424704,4.539898828363559,"['POLD4', 'POLE3', 'GTF2H5']",0.9981566507682293,0,0,3
26,DNA Repair Pathways Full Network WP4946,0.18681038477032272,1.7802570943487752,2.9866681851077153,"['POLD4', 'CENPX', 'APEX1', 'POLE3', 'GTF2H5']",0.9981566507682293,0,0,5
27,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.19676968018588892,2.9864864864864864,4.855194903280355,"['H2AFZ', 'HIST1H3E']",0.9981566507682293,0,0,2
28,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.19676968018588892,2.9864864864864864,4.855194903280355,"['ZAP70', 'HLA-DRB1']",0.9981566507682293,0,0,2
29,MED and Pseudoachondroplasia genes WP4789,0.2227141797343059,7.460370994940978,11.204477804577618,['COL9A3'],0.9981566507682293,0,0,1
30,Peroxiredoxin 2 induced ovarian failure WP4873,0.2227141797343059,7.460370994940978,11.204477804577618,['BAX'],0.9981566507682293,0,0,1
31,Purine metabolism WP4792,0.2227141797343059,7.460370994940978,11.204477804577618,['APRT'],0.9981566507682293,0,0,1
32,Selenium Micronutrient Network WP15,0.22767723370919254,1.5467980295566504,2.288992396606385,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOH']",0.9981566507682293,0,0,6
33,Serotonin and anxiety WP3947,0.2428411396691854,2.488175675675676,3.5216339577430116,"['POMC', 'CRH']",0.9981566507682293,0,0,2
34,Cancer immunotherapy by PD-1 blockade WP4585,0.2428411396691854,2.488175675675676,3.5216339577430116,"['ZAP70', 'HLA-DRB1']",0.9981566507682293,0,0,2
35,Complement Activation WP545,0.2428411396691854,2.488175675675676,3.5216339577430116,"['C1QA', 'C1QC']",0.9981566507682293,0,0,2
36,NOTCH1 regulation of endothelial cell calcification WP3413,0.2428411396691854,2.488175675675676,3.5216339577430116,"['SOX6', 'DLL3']",0.9981566507682293,0,0,2
37,Allograft Rejection WP2328,0.28624529433889806,1.5721677074041034,1.9666342748379997,"['C1QA', 'HLA-B', 'HLA-DRB1', 'C1QC']",0.9981566507682293,0,0,4
38,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.28624529433889806,1.5721677074041034,1.9666342748379997,"['AXL', 'RPS6', 'BAX', 'HRAS']",0.9981566507682293,0,0,4
39,TP53 network WP1742,0.28927379827994215,2.132239382239382,2.644790582830157,"['SUMO1', 'BAX']",0.9981566507682293,0,0,2
40,DNA Mismatch Repair WP531,0.28927379827994215,2.132239382239382,2.644790582830157,"['POLD4', 'POLE3']",0.9981566507682293,0,0,2
41,Histone Modifications WP2369,0.28927379827994215,2.132239382239382,2.644790582830157,"['SET', 'HIST1H3E']",0.9981566507682293,0,0,2
42,Translation Factors WP107,0.2922041062427662,1.7227645450995706,2.11952191766726,"['EEF1B2', 'EIF3D', 'EIF1']",0.9981566507682293,0,0,3
43,Non-small cell lung cancer WP4255,0.2922041062427662,1.7227645450995706,2.11952191766726,"['CYCS', 'BAX', 'HRAS']",0.9981566507682293,0,0,3
44,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.314278033040035,1.493220338983051,1.7283685407257057,"['POMC', 'RPS6', 'ZNF516', 'HRAS']",0.9981566507682293,0,0,4
45,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.31474271817093163,3.7293423271500843,4.311118766539533,['IDH3B'],0.9981566507682293,0,0,1
46,Benzo(a)pyrene metabolism WP696,0.31474271817093163,3.7293423271500843,4.311118766539533,['AKR1C3'],0.9981566507682293,0,0,1
47,Canonical NF-KB pathway WP4562,0.31474271817093163,3.7293423271500843,4.311118766539533,['NFKBIE'],0.9981566507682293,0,0,1
48,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.335338056019841,1.865287162162162,2.0380428470476786,"['MFGE8', 'HRAS']",0.9981566507682293,0,0,2
49,Glycosylation and related congenital defects WP4521,0.335338056019841,1.865287162162162,2.0380428470476786,"['DPM2', 'DPM3']",0.9981566507682293,0,0,2
50,Interferon type I signaling pathways WP585,0.335338056019841,1.865287162162162,2.0380428470476786,"['ZAP70', 'RPS6']",0.9981566507682293,0,0,2
51,MET in type 1 papillary renal cell carcinoma WP4205,0.335338056019841,1.865287162162162,2.0380428470476786,"['RPL11', 'HRAS']",0.9981566507682293,0,0,2
52,Nanomaterial induced apoptosis WP2507,0.335338056019841,1.865287162162162,2.0380428470476786,"['BAX', 'CYCS']",0.9981566507682293,0,0,2
53,Thermogenesis WP4321,0.34253125038236726,1.4217917675544793,1.5232968706095564,"['RPS6', 'ZNF516', 'CPT1B', 'HRAS']",0.9981566507682293,0,0,4
54,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3604982085639755,1.4923857868020305,1.5226338970770519,"['APEX1', 'RPS6', 'HRAS']",0.9981566507682293,0,0,3
55,Endometrial cancer WP4155,0.3604982085639755,1.4923857868020305,1.5226338970770519,"['BAX', 'FGF1', 'HRAS']",0.9981566507682293,0,0,3
56,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3682544001566395,1.124277235011733,1.1231319055514883,"['SET', 'RPS6', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9981566507682293,0,0,17
57,Interleukin-11 Signaling Pathway WP2332,0.380471444625103,1.6576576576576576,1.601867782623488,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
58,Serotonin and anxiety-related events WP3944,0.3958914885171806,2.4856661045531196,2.3032558061248527,['CRH'],0.9981566507682293,0,0,1
59,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3958914885171806,2.4856661045531196,2.3032558061248527,['DLL3'],0.9981566507682293,0,0,1
60,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3958914885171806,2.4856661045531196,2.3032558061248527,['COX8A'],0.9981566507682293,0,0,1
61,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3958914885171806,2.4856661045531196,2.3032558061248527,['HIST1H3E'],0.9981566507682293,0,0,1
62,Glutathione metabolism WP100,0.3958914885171806,2.4856661045531196,2.3032558061248527,['GPX4'],0.9981566507682293,0,0,1
63,"GPCRs, Class B Secretin-like WP334",0.3958914885171806,2.4856661045531196,2.3032558061248527,['ADGRL2'],0.9981566507682293,0,0,1
64,Homologous recombination WP186,0.3958914885171806,2.4856661045531196,2.3032558061248527,['POLD4'],0.9981566507682293,0,0,1
65,Macrophage markers WP4146,0.3958914885171806,2.4856661045531196,2.3032558061248527,['CD74'],0.9981566507682293,0,0,1
66,MTHFR deficiency WP4288,0.3958914885171806,2.4856661045531196,2.3032558061248527,['CYCS'],0.9981566507682293,0,0,1
67,Amyotrophic lateral sclerosis (ALS) WP2447,0.4242493892454496,1.491554054054054,1.2789088820689696,"['BAX', 'NEFH']",0.9981566507682293,0,0,2
68,Type 2 papillary renal cell carcinoma WP4241,0.4242493892454496,1.491554054054054,1.2789088820689696,"['ELOB', 'ELOC']",0.9981566507682293,0,0,2
69,Copper homeostasis WP3286,0.4242493892454496,1.491554054054054,1.2789088820689696,"['COX17', 'ATOX1']",0.9981566507682293,0,0,2
70,IL-2 signaling pathway WP49,0.4242493892454496,1.491554054054054,1.2789088820689696,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
71,Parkinson's disease pathway WP2371,0.4242493892454496,1.491554054054054,1.2789088820689696,"['CYCS', 'PARK7']",0.9981566507682293,0,0,2
72,Leptin signaling pathway WP2034,0.42774040149096426,1.316213795162735,1.1177798318339198,"['RPS6', 'BAX', 'HRAS']",0.9981566507682293,0,0,3
73,Ciliary landscape WP4352,0.4401515750649583,1.135212206503222,0.9315961434826117,"['COPS6', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'COX6C', 'LSM4']",0.9981566507682293,0,0,7
74,IL-18 signaling pathway WP4754,0.4564419004387289,1.079692154915591,0.8467959265089307,"['NRN1', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'BPGM', 'RPS11', 'NFKBIE', 'RND2', 'ABCF1']",0.9981566507682293,0,0,11
75,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4674447978839033,1.8638279932546373,1.4173927603154877,['HRAS'],0.9981566507682293,0,0,1
76,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4674447978839033,1.8638279932546373,1.4173927603154877,['NFKBIE'],0.9981566507682293,0,0,1
77,Cancer immunotherapy by CTLA4 blockade WP4582,0.4674447978839033,1.8638279932546373,1.4173927603154877,['HLA-DRB1'],0.9981566507682293,0,0,1
78,Type II diabetes mellitus WP1584,0.4674447978839033,1.8638279932546373,1.4173927603154877,['SURF1'],0.9981566507682293,0,0,1
79,Fatty acid transporters WP5061,0.4674447978839033,1.8638279932546373,1.4173927603154877,['FABP6'],0.9981566507682293,0,0,1
80,Genes targeted by miRNAs in adipocytes WP1992,0.4674447978839033,1.8638279932546373,1.4173927603154877,['TMSB4X'],0.9981566507682293,0,0,1
81,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4674447978839033,1.8638279932546373,1.4173927603154877,['HRAS'],0.9981566507682293,0,0,1
82,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4674447978839033,1.8638279932546373,1.4173927603154877,['VEGFB'],0.9981566507682293,0,0,1
83,Purine metabolism and related disorders WP4224,0.4674447978839033,1.8638279932546373,1.4173927603154877,['APRT'],0.9981566507682293,0,0,1
84,RalA downstream regulated genes WP2290,0.4674447978839033,1.8638279932546373,1.4173927603154877,['HRAS'],0.9981566507682293,0,0,1
85,TNF-alpha signaling pathway WP231,0.48191502239132145,1.1470664928292047,0.8373441814376604,"['BAX', 'TXN', 'NFKBIE', 'HRAS']",0.9981566507682293,0,0,4
86,Prolactin Signaling Pathway WP2037,0.492309680318709,1.1771306438685547,0.8341704866105156,"['ZAP70', 'RPS6', 'HRAS']",0.9981566507682293,0,0,3
87,Kit receptor signaling pathway WP304,0.5065859543278579,1.2423986486486487,0.8449071993282151,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
88,Lung fibrosis WP3624,0.5065859543278579,1.2423986486486487,0.8449071993282151,"['DSP', 'FGF1']",0.9981566507682293,0,0,2
89,Acute viral myocarditis WP4298,0.5232193219438017,1.118020304568528,0.7242027383826066,"['CYCS', 'BAX', 'AIF1']",0.9981566507682293,0,0,3
90,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5232193219438017,1.118020304568528,0.7242027383826066,"['PSMC5', 'PSMD7', 'PSMC1']",0.9981566507682293,0,0,3
91,Apoptosis Modulation by HSP70 WP384,0.530535575079464,1.4907251264755481,0.944923347496623,['CYCS'],0.9981566507682293,0,0,1
92,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.530535575079464,1.4907251264755481,0.944923347496623,['HSD11B2'],0.9981566507682293,0,0,1
93,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.530535575079464,1.4907251264755481,0.944923347496623,['TBXAS1'],0.9981566507682293,0,0,1
94,Fatty Acid Biosynthesis WP357,0.530535575079464,1.4907251264755481,0.944923347496623,['ECHDC3'],0.9981566507682293,0,0,1
95,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.530535575079464,1.4907251264755481,0.944923347496623,['RPS6'],0.9981566507682293,0,0,1
96,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.530535575079464,1.4907251264755481,0.944923347496623,['BAX'],0.9981566507682293,0,0,1
97,miR-509-3p alteration of YAP1/ECM axis WP3967,0.530535575079464,1.4907251264755481,0.944923347496623,['SPARC'],0.9981566507682293,0,0,1
98,miRNA regulation of p53 pathway in prostate cancer WP3982,0.530535575079464,1.4907251264755481,0.944923347496623,['BAX'],0.9981566507682293,0,0,1
99,Nanoparticle-mediated activation of receptor signaling WP2643,0.530535575079464,1.4907251264755481,0.944923347496623,['HRAS'],0.9981566507682293,0,0,1
100,Nucleotide metabolism WP404,0.530535575079464,1.4907251264755481,0.944923347496623,['NME2'],0.9981566507682293,0,0,1
101,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.530535575079464,1.4907251264755481,0.944923347496623,['ANAPC11'],0.9981566507682293,0,0,1
102,"Relationship between inflammation, COX-2 and EGFR WP4483",0.530535575079464,1.4907251264755481,0.944923347496623,['HRAS'],0.9981566507682293,0,0,1
103,Ebola Virus Pathway on Host WP4217,0.5345687245430909,1.0646489104116224,0.6667842675495144,"['AXL', 'HLA-B', 'MFGE8', 'HLA-DRB1']",0.9981566507682293,0,0,4
104,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5447817102852934,1.1465696465696467,0.6963921164678812,"['IFI27L2', 'HRAS']",0.9981566507682293,0,0,2
105,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5447817102852934,1.1465696465696467,0.6963921164678812,"['NDUFA13', 'COPS6']",0.9981566507682293,0,0,2
106,Apoptosis WP254,0.5530680599332166,1.0645395213923132,0.6304993051242619,"['CYCS', 'BAX', 'NFKBIE']",0.9981566507682293,0,0,3
107,Microglia Pathogen Phagocytosis Pathway WP3937,0.5808642007730639,1.064430501930502,0.5782393983047466,"['C1QA', 'C1QC']",0.9981566507682293,0,0,2
108,Airway smooth muscle cell contraction WP4962,0.5861631847761537,1.2419898819561552,0.6634176587499911,['PPP1R14A'],0.9981566507682293,0,0,1
109,BDNF-TrkB Signaling WP3676,0.5861631847761537,1.2419898819561552,0.6634176587499911,['HRAS'],0.9981566507682293,0,0,1
110,Cytokines and Inflammatory Response WP530,0.5861631847761537,1.2419898819561552,0.6634176587499911,['HLA-DRB1'],0.9981566507682293,0,0,1
111,Eicosanoid Synthesis WP167,0.5861631847761537,1.2419898819561552,0.6634176587499911,['TBXAS1'],0.9981566507682293,0,0,1
112,ERK Pathway in Huntington's Disease WP3853,0.5861631847761537,1.2419898819561552,0.6634176587499911,['HRAS'],0.9981566507682293,0,0,1
113,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5861631847761537,1.2419898819561552,0.6634176587499911,['RPS6'],0.9981566507682293,0,0,1
114,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5861631847761537,1.2419898819561552,0.6634176587499911,['SUPT4H1'],0.9981566507682293,0,0,1
115,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5861631847761537,1.2419898819561552,0.6634176587499911,['BAX'],0.9981566507682293,0,0,1
116,Matrix Metalloproteinases WP129,0.5861631847761537,1.2419898819561552,0.6634176587499911,['MMP26'],0.9981566507682293,0,0,1
117,Methionine De Novo and Salvage Pathway WP3580,0.5861631847761537,1.2419898819561552,0.6634176587499911,['TXN'],0.9981566507682293,0,0,1
118,PDGFR-beta pathway WP3972,0.5861631847761537,1.2419898819561552,0.6634176587499911,['HRAS'],0.9981566507682293,0,0,1
119,Pyrimidine metabolism and related diseases WP4225,0.5861631847761537,1.2419898819561552,0.6634176587499911,['NT5C'],0.9981566507682293,0,0,1
120,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5861631847761537,1.2419898819561552,0.6634176587499911,['BAX'],0.9981566507682293,0,0,1
121,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6092906485461529,0.9715294636945486,0.4813538615015078,"['CTSV', 'SOX6', 'SLC38A2']",0.9981566507682293,0,0,3
122,Endochondral Ossification WP474,0.6092906485461529,0.9715294636945486,0.4813538615015078,"['CTSV', 'SOX6', 'SLC38A2']",0.9981566507682293,0,0,3
123,Sleep regulation WP3591,0.6147979423100434,0.9932432432432432,0.48317471145007607,"['CRH', 'HCRTR1']",0.9981566507682293,0,0,2
124,Ferroptosis WP4313,0.6147979423100434,0.9932432432432432,0.48317471145007607,"['GPX4', 'FTH1']",0.9981566507682293,0,0,2
125,PPAR signaling pathway WP3942,0.6147979423100434,0.9932432432432432,0.48317471145007607,"['FABP6', 'CPT1B']",0.9981566507682293,0,0,2
126,Statin inhibition of cholesterol production WP430,0.6352091498553688,1.0643218501565888,0.48299028210629114,['APOC1'],0.9981566507682293,0,0,1
127,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6352091498553688,1.0643218501565888,0.48299028210629114,['ZAP70'],0.9981566507682293,0,0,1
128,Biomarkers for pyrimidine metabolism disorders WP4584,0.6352091498553688,1.0643218501565888,0.48299028210629114,['NT5C'],0.9981566507682293,0,0,1
129,Fatty acid beta-oxidation WP143,0.6352091498553688,1.0643218501565888,0.48299028210629114,['CPT1B'],0.9981566507682293,0,0,1
130,MAPK Cascade WP422,0.6352091498553688,1.0643218501565888,0.48299028210629114,['HRAS'],0.9981566507682293,0,0,1
131,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6352091498553688,1.0643218501565888,0.48299028210629114,['SOX6'],0.9981566507682293,0,0,1
132,Overview of nanoparticle effects WP3287,0.6352091498553688,1.0643218501565888,0.48299028210629114,['BAX'],0.9981566507682293,0,0,1
133,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6352091498553688,1.0643218501565888,0.48299028210629114,['HRAS'],0.9981566507682293,0,0,1
134,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6352091498553688,1.0643218501565888,0.48299028210629114,['BAX'],0.9981566507682293,0,0,1
135,Cytosolic DNA-sensing pathway WP4655,0.6465853817973277,0.9309543918918919,0.40594268282817003,"['POLR2K', 'POLR2L']",0.9981566507682293,0,0,2
136,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.649198590755621,0.907698041326763,0.392140634424678,"['DSP', 'SPARC', 'GDF15', 'HRAS', 'DLL3']",0.9981566507682293,0,0,5
137,22q11.2 copy number variation syndrome WP4657,0.6605885946900527,0.8934010152284264,0.37042553045829446,"['RANBP1', 'MRPL40', 'EMC10']",0.9981566507682293,0,0,3
138,Androgen receptor signaling pathway WP138,0.6605885946900527,0.8934010152284264,0.37042553045829446,"['SUMO1', 'BAG1', 'PARK7']",0.9981566507682293,0,0,3
139,Genotoxicity pathway WP4286,0.676258441223838,0.875993640699523,0.3426711630213977,"['RPS27', 'TRIAP1']",0.9981566507682293,0,0,2
140,Integrin-mediated Cell Adhesion WP185,0.676258441223838,0.875993640699523,0.3426711630213977,"['ITGA8', 'HRAS']",0.9981566507682293,0,0,2
141,p53 transcriptional gene network WP4963,0.676258441223838,0.875993640699523,0.3426711630213977,"['SIVA1', 'BAX']",0.9981566507682293,0,0,2
142,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6784510260529553,0.931070826306914,0.36120239285041716,['HRAS'],0.9981566507682293,0,0,1
143,Alpha 6 Beta 4 signaling pathway WP244,0.6784510260529553,0.931070826306914,0.36120239285041716,['HRAS'],0.9981566507682293,0,0,1
144,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6784510260529553,0.931070826306914,0.36120239285041716,['HRAS'],0.9981566507682293,0,0,1
145,Galanin receptor pathway WP4970,0.6784510260529553,0.931070826306914,0.36120239285041716,['POMC'],0.9981566507682293,0,0,1
146,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6784510260529553,0.931070826306914,0.36120239285041716,['HRAS'],0.9981566507682293,0,0,1
147,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7038715275027507,0.8271396396396397,0.2904578834102236,"['CYCS', 'BAX']",0.9981566507682293,0,0,2
148,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7165746456756117,0.8274311410905003,0.2757603396632926,['HRAS'],0.9981566507682293,0,0,1
149,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7165746456756117,0.8274311410905003,0.2757603396632926,['RPS6'],0.9981566507682293,0,0,1
150,Type II interferon signaling (IFNG) WP619,0.7165746456756117,0.8274311410905003,0.2757603396632926,['HLA-B'],0.9981566507682293,0,0,1
151,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7165746456756117,0.8274311410905003,0.2757603396632926,['FGF1'],0.9981566507682293,0,0,1
152,7q11.23 copy number variation syndrome WP4932,0.7280784722384394,0.7971356055112401,0.2529681506383265,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9981566507682293,0,0,3
153,Complement system WP2806,0.7280784722384394,0.7971356055112401,0.2529681506383265,"['FCGR3A', 'RPS19', 'TXN']",0.9981566507682293,0,0,3
154,T-cell receptor (TCR) signaling pathway WP69,0.729495779552372,0.7834281650071123,0.24709457227721537,"['ZAP70', 'HRAS']",0.9981566507682293,0,0,2
155,Oncostatin M Signaling Pathway WP2374,0.729495779552372,0.7834281650071123,0.24709457227721537,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
156,Hippo-Merlin Signaling Dysregulation WP4541,0.7480966978139262,0.7694731314545773,0.22331882695432892,"['PPP1R14A', 'ITGA8', 'HRAS']",0.9981566507682293,0,0,3
157,7-oxo-C and 7beta-HC pathways WP5064,0.7501849213214439,0.7445193929173693,0.21400133454865916,['HSD11B2'],0.9981566507682293,0,0,1
158,Canonical and non-canonical Notch signaling WP3845,0.7501849213214439,0.7445193929173693,0.21400133454865916,['DLL3'],0.9981566507682293,0,0,1
159,Vitamin D-sensitive calcium signaling in depression WP4698,0.7501849213214439,0.7445193929173693,0.21400133454865916,['GPX4'],0.9981566507682293,0,0,1
160,Genes controlling nephrogenesis WP4823,0.7501849213214439,0.7445193929173693,0.21400133454865916,['ITGA8'],0.9981566507682293,0,0,1
161,Imatinib and Chronic Myeloid Leukemia WP3640,0.7501849213214439,0.7445193929173693,0.21400133454865916,['SKP2'],0.9981566507682293,0,0,1
162,Inflammatory Response Pathway WP453,0.7501849213214439,0.7445193929173693,0.21400133454865916,['ZAP70'],0.9981566507682293,0,0,1
163,Notch Signaling WP268,0.7501849213214439,0.7445193929173693,0.21400133454865916,['DLL3'],0.9981566507682293,0,0,1
164,One-carbon metabolism and related pathways WP3940,0.7501849213214439,0.7445193929173693,0.21400133454865916,['GPX4'],0.9981566507682293,0,0,1
165,PDGF Pathway WP2526,0.7501849213214439,0.7445193929173693,0.21400133454865916,['HRAS'],0.9981566507682293,0,0,1
166,Pregnane X receptor pathway WP2876,0.7501849213214439,0.7445193929173693,0.21400133454865916,['PSMC5'],0.9981566507682293,0,0,1
167,Regulation of Microtubule Cytoskeleton WP2038,0.7501849213214439,0.7445193929173693,0.21400133454865916,['PARD6A'],0.9981566507682293,0,0,1
168,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7532143587514608,0.7440878378378378,0.2108785252448081,"['DSP', 'ITGA8']",0.9981566507682293,0,0,2
169,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7532143587514608,0.7440878378378378,0.2108785252448081,"['TMSB4X', 'NEFH']",0.9981566507682293,0,0,2
170,Head and Neck Squamous Cell Carcinoma WP4674,0.7532143587514608,0.7440878378378378,0.2108785252448081,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
171,Metapathway biotransformation Phase I and II WP702,0.7661390484624545,0.7624511082138201,0.20311057087321868,"['HS3ST3B1', 'GPX4', 'GSTO1', 'AKR1C3']",0.9981566507682293,0,0,4
172,DNA damage response WP707,0.7751186166463817,0.7084942084942085,0.1804812532631659,"['CYCS', 'BAX']",0.9981566507682293,0,0,2
173,Glucocorticoid Receptor Pathway WP2880,0.7751186166463817,0.7084942084942085,0.1804812532631659,"['SRGN', 'MFGE8']",0.9981566507682293,0,0,2
174,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7751186166463817,0.7084942084942085,0.1804812532631659,"['BAX', 'HRAS']",0.9981566507682293,0,0,2
175,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7798153792268205,0.676682508048444,0.1682896409365312,['RPS6'],0.9981566507682293,0,0,1
176,CAMKK2  Pathway WP4874,0.7798153792268205,0.676682508048444,0.1682896409365312,['FIS1'],0.9981566507682293,0,0,1
177,Integrated Cancer Pathway WP1971,0.7798153792268205,0.676682508048444,0.1682896409365312,['BAX'],0.9981566507682293,0,0,1
178,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7798153792268205,0.676682508048444,0.1682896409365312,['CYCS'],0.9981566507682293,0,0,1
179,p38 MAPK Signaling Pathway WP400,0.7798153792268205,0.676682508048444,0.1682896409365312,['HRAS'],0.9981566507682293,0,0,1
180,Melanoma WP4685,0.7953049991507486,0.6761363636363636,0.15485523493941114,"['BAX', 'HRAS']",0.9981566507682293,0,0,2
181,miRNA regulation of DNA damage response WP1530,0.7953049991507486,0.6761363636363636,0.15485523493941114,"['CYCS', 'BAX']",0.9981566507682293,0,0,2
182,Neural Crest Differentiation WP2064,0.7953049991507486,0.6761363636363636,0.15485523493941114,"['PRTG', 'DLL3']",0.9981566507682293,0,0,2
183,Spinal Cord Injury WP2431,0.796752127120558,0.7249276560562216,0.1647120131704781,"['BCAN', 'APEX1', 'LILRB3', 'AIF1']",0.9981566507682293,0,0,4
184,Breast cancer pathway WP4262,0.796752127120558,0.7249276560562216,0.1647120131704781,"['BAX', 'FGF1', 'HRAS', 'DLL3']",0.9981566507682293,0,0,4
185,Endothelin Pathways WP2197,0.8059365710156261,0.6201517706576728,0.1337978906163543,['RIIAD1'],0.9981566507682293,0,0,1
186,Heart Development WP1591,0.8059365710156261,0.6201517706576728,0.1337978906163543,['VEGFB'],0.9981566507682293,0,0,1
187,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8059365710156261,0.6201517706576728,0.1337978906163543,['BAX'],0.9981566507682293,0,0,1
188,Corticotropin-releasing hormone signaling pathway WP2355,0.8138725664539813,0.6465922444183314,0.13316662807994814,"['POMC', 'CRH']",0.9981566507682293,0,0,2
189,Retinoblastoma gene in cancer WP2446,0.8138725664539813,0.6465922444183314,0.13316662807994814,"['H2AFZ', 'SKP2']",0.9981566507682293,0,0,2
190,Regulation of Actin Cytoskeleton WP51,0.8165843387282615,0.6755883710198431,0.136891146991014,"['TMSB4X', 'BRK1', 'FGF1']",0.9981566507682293,0,0,3
191,Aryl Hydrocarbon Receptor Pathway WP2873,0.8289634959608451,0.5723180697885588,0.10735494200496262,['BAX'],0.9981566507682293,0,0,1
192,TGF-beta Receptor Signaling WP560,0.8289634959608451,0.5723180697885588,0.10735494200496262,['HRAS'],0.9981566507682293,0,0,1
193,Bladder cancer WP2828,0.8289634959608451,0.5723180697885588,0.10735494200496262,['HRAS'],0.9981566507682293,0,0,1
194,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8289634959608451,0.5723180697885588,0.10735494200496262,['CYCS'],0.9981566507682293,0,0,1
195,IL-5 signaling pathway WP127,0.8289634959608451,0.5723180697885588,0.10735494200496262,['RPS6'],0.9981566507682293,0,0,1
196,MECP2 and Associated Rett Syndrome WP3584,0.8289634959608451,0.5723180697885588,0.10735494200496262,['RPS6'],0.9981566507682293,0,0,1
197,Complement and Coagulation Cascades WP558,0.8309210272357184,0.6195101351351351,0.11474599064706335,"['C1QA', 'C1QC']",0.9981566507682293,0,0,2
198,ESC Pluripotency Pathways WP3931,0.8309210272357184,0.6195101351351351,0.11474599064706335,"['FGF1', 'HRAS']",0.9981566507682293,0,0,2
199,EGF/EGFR signaling pathway WP437,0.831015033319853,0.6555688265153777,0.12135063683622947,"['NDUFA13', 'NEDD8', 'HRAS']",0.9981566507682293,0,0,3
200,Hepatitis B infection WP4666,0.831015033319853,0.6555688265153777,0.12135063683622947,"['CYCS', 'BAX', 'HRAS']",0.9981566507682293,0,0,3
201,Aryl Hydrocarbon Receptor Netpath WP2586,0.8492621492124477,0.5313177547578897,0.08681060858106437,['HRAS'],0.9981566507682293,0,0,1
202,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8492621492124477,0.5313177547578897,0.08681060858106437,['HRAS'],0.9981566507682293,0,0,1
203,Development of ureteric collection system WP5053,0.8492621492124477,0.5313177547578897,0.08681060858106437,['ITGA8'],0.9981566507682293,0,0,1
204,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8492621492124477,0.5313177547578897,0.08681060858106437,['BAX'],0.9981566507682293,0,0,1
205,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8492621492124477,0.5313177547578897,0.08681060858106437,['PPP1R14A'],0.9981566507682293,0,0,1
206,IL-3 signaling pathway WP286,0.8492621492124477,0.5313177547578897,0.08681060858106437,['HRAS'],0.9981566507682293,0,0,1
207,Nephrotic syndrome WP4758,0.8492621492124477,0.5313177547578897,0.08681060858106437,['EMP2'],0.9981566507682293,0,0,1
208,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8492621492124477,0.5313177547578897,0.08681060858106437,['BAX'],0.9981566507682293,0,0,1
209,Small cell lung cancer WP4658,0.8608538295778224,0.5715956340956341,0.08564249233189129,"['CYCS', 'BAX']",0.9981566507682293,0,0,2
210,DNA damage response (only ATM dependent) WP710,0.8608538295778224,0.5715956340956341,0.08564249233189129,"['BAX', 'HRAS']",0.9981566507682293,0,0,2
211,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8671553001456562,0.4957841483979764,0.07066768166966207,['RNF7'],0.9981566507682293,0,0,1
212,DNA Replication WP466,0.8671553001456562,0.4957841483979764,0.07066768166966207,['POLD4'],0.9981566507682293,0,0,1
213,Notch Signaling Pathway Netpath WP61,0.8671553001456562,0.4957841483979764,0.07066768166966207,['DLL3'],0.9981566507682293,0,0,1
214,Pathways affected in adenoid cystic carcinoma WP3651,0.8671553001456562,0.4957841483979764,0.07066768166966207,['HRAS'],0.9981566507682293,0,0,1
215,Alzheimer's disease WP2059,0.8739286923574936,0.5503003003003003,0.07415653930641203,"['ATP5MD', 'CYCS']",0.9981566507682293,0,0,2
216,Synaptic Vesicle Pathway WP2267,0.8829275894840947,0.46469224283305227,0.057859800900499705,['PARK7'],0.9981566507682293,0,0,1
217,Glioblastoma signaling pathways WP2261,0.8829275894840947,0.46469224283305227,0.057859800900499705,['HRAS'],0.9981566507682293,0,0,1
218,TGF-beta Signaling Pathway WP366,0.8967456701670727,0.5121155638397018,0.055811885855519654,"['PARD6A', 'SUMO1']",0.9981566507682293,0,0,2
219,AGE/RAGE pathway WP2324,0.8968300270769582,0.4372582085110604,0.047612576410848026,['CYCS'],0.9981566507682293,0,0,1
220,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8968300270769582,0.4372582085110604,0.047612576410848026,['HRAS'],0.9981566507682293,0,0,1
221,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8968300270769582,0.4372582085110604,0.047612576410848026,['ZAP70'],0.9981566507682293,0,0,1
222,G Protein Signaling Pathways WP35,0.8968300270769582,0.4372582085110604,0.047612576410848026,['HRAS'],0.9981566507682293,0,0,1
223,AMP-activated protein kinase (AMPK) signaling WP1403,0.9090839592485628,0.4128724002248454,0.03935409905163786,['CPT1B'],0.9981566507682293,0,0,1
224,Differentiation Pathway WP2848,0.9090839592485628,0.4128724002248454,0.03935409905163786,['FGF1'],0.9981566507682293,0,0,1
225,ErbB signaling pathway WP673,0.9090839592485628,0.4128724002248454,0.03935409905163786,['HRAS'],0.9981566507682293,0,0,1
226,Folate Metabolism WP176,0.9090839592485628,0.4128724002248454,0.03935409905163786,['GPX4'],0.9981566507682293,0,0,1
227,NRF2 pathway WP2884,0.915023138244198,0.5297316896301668,0.0470433134027802,"['FTH1', 'TXN', 'SLC5A3']",0.9981566507682293,0,0,3
228,Vitamin D Receptor Pathway WP2877,0.9187686106262969,0.5592580748321074,0.047380887808381185,"['COLEC11', 'S100A6', 'S100A8', 'HLA-DRB1']",0.9981566507682293,0,0,4
229,Myometrial relaxation and contraction pathways WP289,0.9187686106262969,0.5592580748321074,0.047380887808381185,"['GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9981566507682293,0,0,4
230,16p11.2 proximal deletion syndrome WP4949,0.9198845692541914,0.39105351912665304,0.032655739466268034,['SEZ6L2'],0.9981566507682293,0,0,1
231,TYROBP causal network in microglia WP3945,0.9198845692541914,0.39105351912665304,0.032655739466268034,['C1QC'],0.9981566507682293,0,0,1
232,Apoptosis Modulation and Signaling WP1772,0.9238639031009005,0.46378800675675674,0.036727608418323655,"['CYCS', 'BAX']",0.9981566507682293,0,0,2
233,Osteoblast differentiation WP4787,0.9313028116422504,0.44963144963144963,0.032000630158890486,"['FGF1', 'DLL3']",0.9981566507682293,0,0,2
234,Pancreatic adenocarcinoma pathway WP4263,0.9377939031391537,0.3536497229583233,0.02271317948053394,['BAX'],0.9981566507682293,0,0,1
235,Peptide GPCRs WP24,0.9377939031391537,0.3536497229583233,0.02271317948053394,['HCRTR1'],0.9981566507682293,0,0,1
236,Prader-Willi and Angelman Syndrome WP3998,0.9377939031391537,0.3536497229583233,0.02271317948053394,['POMC'],0.9981566507682293,0,0,1
237,Senescence and Autophagy in Cancer WP615,0.9380509258717301,0.43630763116057236,0.027902326543830132,"['SPARC', 'HRAS']",0.9981566507682293,0,0,2
238,Integrated breast cancer pathway WP1984,0.9380509258717301,0.43630763116057236,0.027902326543830132,"['BAX', 'FAU']",0.9981566507682293,0,0,2
239,Nuclear Receptors Meta-Pathway WP2882,0.9440000903611566,0.5877148830726343,0.03386943105537816,"['SRGN', 'PSMC5', 'FTH1', 'BAX', 'TXN', 'MFGE8', 'SLC5A3']",0.9981566507682293,0,0,7
240,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9441672316733164,0.42374517374517373,0.02434499769192726,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
241,Cell cycle WP179,0.9497064560587638,0.41188063063063063,0.021254002594129774,"['SKP2', 'ANAPC11']",0.9981566507682293,0,0,2
242,Gastrin signaling pathway WP4659,0.9497064560587638,0.41188063063063063,0.021254002594129774,"['RPS6', 'HRAS']",0.9981566507682293,0,0,2
243,Circadian rhythm related genes WP3594,0.9506616248850028,0.5016949152542373,0.02538430255240365,"['CAVIN3', 'CRH', 'RPS27A', 'HCRTR1']",0.9981566507682293,0,0,4
244,Exercise-induced Circadian Regulation WP410,0.9517048107269472,0.32275093481926825,0.01597628909025911,['SUMO1'],0.9981566507682293,0,0,1
245,Focal Adhesion WP306,0.9551896381071516,0.453330570807003,0.02078311422470496,"['VEGFB', 'ITGA8', 'HRAS']",0.9981566507682293,0,0,3
246,Endoderm differentiation WP2853,0.957447779992694,0.3092327150084317,0.013446705461961682,['NME1'],0.9981566507682293,0,0,1
247,B Cell Receptor Signaling Pathway WP23,0.9625088099666931,0.29679595278246207,0.011341184651584067,['HRAS'],0.9981566507682293,0,0,1
248,Ras signaling WP4223,0.9633489197137787,0.3799376299376299,0.014186721801951421,"['ZAP70', 'HRAS']",0.9981566507682293,0,0,2
249,Chemokine signaling pathway WP3929,0.9774137068560645,0.25562598127580394,0.0058398446764484505,['HRAS'],0.9981566507682293,0,0,1
250,Mesodermal commitment pathway WP2857,0.9774137068560645,0.25562598127580394,0.0058398446764484505,['RPL38'],0.9981566507682293,0,0,1
251,"GPCRs, Class A Rhodopsin-like WP455",0.9794809904969553,0.428002947678703,0.008873549344375125,"['NPFFR1', 'GPR35', 'APLNR', 'HCRTR1']",0.9981566507682293,0,0,4
252,Ectoderm Differentiation WP2858,0.9801026054668026,0.24704890387858347,0.004965192166328621,['PLCXD3'],0.9981566507682293,0,0,1
253,Insulin Signaling WP481,0.9801026054668026,0.24704890387858347,0.004965192166328621,['HRAS'],0.9981566507682293,0,0,1
254,PI3K-Akt signaling pathway WP4172,0.9849742696389854,0.46509129967776586,0.007041370815741339,"['RPS6', 'VEGFB', 'ITGA8', 'COL9A3', 'FGF1', 'HRAS']",0.9981566507682293,0,0,6
255,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.985077675472913,0.43869755032743146,0.006595722283633618,"['RPS6', 'VEGFB', 'ITGA8', 'FGF1', 'HRAS']",0.9981566507682293,0,0,5
256,"GPCRs, Other WP117",0.9880189795249406,0.2177859339351255,0.0026250547415996106,['ADGRL2'],0.9981566507682293,0,0,1
257,Calcium Regulation in the Cardiac Cell WP536,0.9888722660685372,0.2956081081081081,0.003307887345065661,"['GJD2', 'RGS6']",0.9981566507682293,0,0,2
258,Ciliopathies WP4803,0.9907043355411634,0.205593029792018,0.0019200618358927416,['CCDC28B'],0.9981566507682293,0,0,1
259,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9970359891285304,0.1641371557054525,0.0004872267438407109,['CDCA7L'],0.9981566507682293,0,0,1
260,MAPK Signaling Pathway WP382,0.9981566507682293,0.22312653562653562,0.0004116796794245701,"['FGF1', 'HRAS']",0.9981566507682293,0,0,2
